• Je něco špatně v tomto záznamu ?

Resveratrol Protects Cardiac Tissue in Experimental Malignant Hypertension Due to Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Properties

J. Grujić-Milanović, V. Jaćević, Z. Miloradović, D. Jovović, I. Milosavljević, SD. Milanović, N. Mihailović-Stanojević

. 2021 ; 22 (9) : . [pub] 20210508

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018626

Hypertension is one of the most prevalent and powerful contributors of cardiovascular diseases. Malignant hypertension is a relatively rare but extremely severe form of hypertension accompanied with heart, brain, and renal impairment. Resveratrol, a recently described grape-derived, polyphenolic antioxidant molecule, has been proposed as an effective agent in the prevention of cardiovascular diseases. This study was designed to examine chronic resveratrol administration on blood pressure, oxidative stress, and inflammation, with special emphasis on cardiac structure and function in two models of experimental hypertension. The experiments were performed in spontaneously (SHRs) and malignantly hypertensive rats (MHRs). The chronic administration of resveratrol significantly decreased blood pressure in both spontaneously and malignant hypertensive animals. The resveratrol treatment ameliorated morphological changes in the heart tissue. The immunohistochemistry of the heart tissue after resveratrol treatment showed that both TGF-β and Bax were not present in the myocytes of SHRs and were present mainly in the myocytes of MHRs. Resveratrol suppressed lipid peroxidation and significantly improved oxidative status and release of NO. These results suggest that resveratrol prevents hypertrophic and apoptotic consequences induced by high blood pressure with more pronounced effects in malignant hypertension.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018626
003      
CZ-PrNML
005      
20210830100227.0
007      
ta
008      
210728s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms22095006 $2 doi
035    __
$a (PubMed)34066865
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Grujić-Milanović, Jelica $u Laboratory for Experimental Hypertension, Institute for Medical Research, Department for Cardiovascular Research, University of Belgrade, National Institute of the Republic Serbia, 11000 Belgrade, Serbia
245    10
$a Resveratrol Protects Cardiac Tissue in Experimental Malignant Hypertension Due to Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Properties / $c J. Grujić-Milanović, V. Jaćević, Z. Miloradović, D. Jovović, I. Milosavljević, SD. Milanović, N. Mihailović-Stanojević
520    9_
$a Hypertension is one of the most prevalent and powerful contributors of cardiovascular diseases. Malignant hypertension is a relatively rare but extremely severe form of hypertension accompanied with heart, brain, and renal impairment. Resveratrol, a recently described grape-derived, polyphenolic antioxidant molecule, has been proposed as an effective agent in the prevention of cardiovascular diseases. This study was designed to examine chronic resveratrol administration on blood pressure, oxidative stress, and inflammation, with special emphasis on cardiac structure and function in two models of experimental hypertension. The experiments were performed in spontaneously (SHRs) and malignantly hypertensive rats (MHRs). The chronic administration of resveratrol significantly decreased blood pressure in both spontaneously and malignant hypertensive animals. The resveratrol treatment ameliorated morphological changes in the heart tissue. The immunohistochemistry of the heart tissue after resveratrol treatment showed that both TGF-β and Bax were not present in the myocytes of SHRs and were present mainly in the myocytes of MHRs. Resveratrol suppressed lipid peroxidation and significantly improved oxidative status and release of NO. These results suggest that resveratrol prevents hypertrophic and apoptotic consequences induced by high blood pressure with more pronounced effects in malignant hypertension.
650    _2
$a zvířata $7 D000818
650    _2
$a antiflogistika $x farmakologie $x terapeutické užití $7 D000893
650    _2
$a antioxidancia $x terapeutické užití $7 D000975
650    12
$a apoptóza $x účinky léků $7 D017209
650    _2
$a tělesná hmotnost $x účinky léků $7 D001835
650    _2
$a kardiotonika $x farmakologie $x terapeutické užití $7 D002316
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční komory $x účinky léků $x patologie $x patofyziologie $7 D006352
650    _2
$a hemodynamika $x účinky léků $7 D006439
650    _2
$a hypertenze maligní $x farmakoterapie $x enzymologie $x patologie $x patofyziologie $7 D006974
650    _2
$a zánět $x komplikace $x farmakoterapie $7 D007249
650    _2
$a myokard $x patologie $7 D009206
650    _2
$a NG-nitroargininmethylester $x chemie $x farmakologie $7 D019331
650    _2
$a velikost orgánu $x účinky léků $7 D009929
650    _2
$a oxidace-redukce $7 D010084
650    _2
$a potkani inbrední SHR $7 D011918
650    _2
$a resveratrol $x chemie $x farmakologie $x terapeutické užití $7 D000077185
650    _2
$a látky reagující s kyselinou thiobarbiturovou $x metabolismus $7 D017392
650    _2
$a protein X asociovaný s bcl-2 $x metabolismus $7 D051028
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jaćević, Vesna $u Department for Experimental Toxicology and Pharmacology, National Poison Control Centre, Military Medical Academy, 11000 Belgrade, Serbia $u Medical Faculty of the Military Medical Academy, University of Defence, 11000 Belgrade, Serbia $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 500 30 Hradec Kralove, Czech Republic
700    1_
$a Miloradović, Zoran $u Laboratory for Experimental Hypertension, Institute for Medical Research, Department for Cardiovascular Research, University of Belgrade, National Institute of the Republic Serbia, 11000 Belgrade, Serbia
700    1_
$a Jovović, Djurdjica $u Laboratory for Experimental Hypertension, Institute for Medical Research, Department for Cardiovascular Research, University of Belgrade, National Institute of the Republic Serbia, 11000 Belgrade, Serbia
700    1_
$a Milosavljević, Ivica $u Institute of Pathology and Forensic Medicine, Military Medical Academy, 11000 Belgrade, Serbia
700    1_
$a Milanović, Sladjan D $u Institute for Medical Research, Department for Biomedical Engineering and Biophysics, University of Belgrade, National Institute of the Republic Serbia, 11000 Belgrade, Serbia
700    1_
$a Mihailović-Stanojević, Nevena $u Laboratory for Experimental Hypertension, Institute for Medical Research, Department for Cardiovascular Research, University of Belgrade, National Institute of the Republic Serbia, 11000 Belgrade, Serbia
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 9 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34066865 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100227 $b ABA008
999    __
$a ok $b bmc $g 1689656 $s 1139072
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 22 $c 9 $e 20210508 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20210728
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace